# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-133799
Filing Date
2024-12-06
Accepted
2024-12-05 19:45:07
Documents
95
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | celu-20240930.htm iXBRL | 10-Q | 3612339
2 | EX-31.1 | celu-ex31_1.htm | EX-31.1 | 16983
3 | EX-31.2 | celu-ex31_2.htm | EX-31.2 | 16967
4 | EX-32.1 | celu-ex32_1.htm | EX-32.1 | 11155
5 | EX-32.2 | celu-ex32_2.htm | EX-32.2 | 10891
| Complete submission text file | 0000950170-24-133799.txt |  | 17272967

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | celu-20240930.xsd | EX-101.SCH | 2569421
98 | EXTRACTED XBRL INSTANCE DOCUMENT | celu-20240930_htm.xml | XML | 3456811

Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38914 | Film No.: 241530284
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)